Pulmonary Vascular Volume is Associated with DLCO and Fibrotic Score in Idiopathic Pulmonary Fibrosis: an Observational Study

Overview

Journal BMC Med Imaging

Publisher Biomed Central

Specialty Radiology

Date 2022 Apr 24

PMID 35461214

Authors

Wen-Jui Wu

Wei-Ming Huang

Chia-Hao Liang

Chun-Ho Yun

Affiliations

Soon will be listed here.

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) is a disease that primarily occurs in elderly individuals. However, it is difficult to diagnose and has a complex disease course. High-resolution computed tomography (HRCT) and lung function testing are crucial for its diagnosis and follow-up. However, the correlation of HRCT findings with lung function test results has not been extensively investigated.

Methods: This study retrospectively analysed the medical records and images of patients with IPF. Patients with evident emphysema and lung cancer were excluded. The diagnosis of all the included cases was confirmed following a discussion among specialists from multiple disciplines. The correlation of HRCT findings, including fibrotic score, HRCT lung volume, pulmonary artery trunk (PA) diameter and pulmonary vascular volume (PVV), with lung function test parameters, such as forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO), was analysed.

Results: A total of 32 patients were included. Higher fibrotic and PVV scores were significantly correlated with lower DLCO (r = - 0.59, p = 0.01; r = - 0.43, p = 0.03, respectively) but not with FVC. Higher PVV score significantly correlated with higher fibrotic score (r = 0.59, p < 0.01) and PA diameter (r = 0.47, p = 0.006).

Conclusion: Our study demonstrated the structural and functional correlation of IPF. The extent of lung fibrosis (fibrotic score) and PVV score were associated with DLCO but not with FVC. The PA diameter, which reflects the pulmonary artery pressure, was found to be associated with the PVV score.

Citing Articles

Vascular involvement in idiopathic pulmonary fibrosis.

Mondoni M, Rinaldo R, Ryerson C, Albrici C, Baccelli A, Tirelli C ERJ Open Res. 2024; 10(6).

PMID: 39588083 PMC: 11587140. DOI: 10.1183/23120541.00550-2024.

Mexican Hispanics show significant improvement in lung function approximately 1 year after having severe COVID-19.

Cortes-Telles A, Solis-Diaz L, Mateos-Toledo H, Guenette J, Zavorsky G Exp Physiol. 2024; 109(12):2147-2157.

PMID: 39446094 PMC: 11607618. DOI: 10.1113/EP091934.

Relationships of computed tomography-based small vessel indices of the lungs with ventilation heterogeneity and high transfer coefficients in non-smokers with asthma.

Shimizu K, Kimura H, Tanabe N, Chubachi S, Sato S, Suzuki M Front Physiol. 2023; 14:1137603.

PMID: 36935740 PMC: 10014854. DOI: 10.3389/fphys.2023.1137603.

Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay.

Yeh J, Syue S, Sun Y, Yeh Y, Zheng Y, Lin C Biomedicines. 2022; 10(6).

PMID: 35740313 PMC: 9219797. DOI: 10.3390/biomedicines10061290.

References

Jacob J, Pienn M, Payer C, Urschler M, Kokosi M, Devaraj A . Quantitative CT-derived vessel metrics in idiopathic pulmonary fibrosis: A structure-function study. Respirology. 2019; 24(5):445-452. PMC: 6519024. DOI: 10.1111/resp.13485. View

Carvalhaes-Neto N, Lorino H, Gallinari C, Escolano S, Mallet A, Zerah F . Cognitive function and assessment of lung function in the elderly. Am J Respir Crit Care Med. 1995; 152(5 Pt 1):1611-5. DOI: 10.1164/ajrccm.152.5.7582303. View

Lynch D, Moore C, Wilson C, Nevrekar D, Jennermann T, Humphries S . CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study. Radiology. 2018; 288(3):859-866. PMC: 6122195. DOI: 10.1148/radiol.2018172294. View

Plantier L, Cazes A, Dinh-Xuan A, Bancal C, Marchand-Adam S, Crestani B . Physiology of the lung in idiopathic pulmonary fibrosis. Eur Respir Rev. 2018; 27(147). PMC: 9489199. DOI: 10.1183/16000617.0062-2017. View

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View

Martinez F, Flaherty K . Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3(4):315-21. PMC: 2658684. DOI: 10.1513/pats.200602-022TK. View

Jacob J, Bartholmai B, Rajagopalan S, Kokosi M, Nair A, Karwoski R . Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. Eur Respir J. 2016; 49(1). DOI: 10.1183/13993003.01011-2016. View

Cortes-Telles A, Forkert L, ODonnell D, Moran-Mendoza O . Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis. Can Respir J. 2014; 21(3):e55-60. PMC: 4128468. DOI: 10.1155/2014/825606. View

Richeldi L, du Bois R, Raghu G, Azuma A, Brown K, Costabel U . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2071-82. DOI: 10.1056/NEJMoa1402584. View

10.

Goh N, Desai S, Veeraraghavan S, Hansell D, Copley S, Maher T . Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008; 177(11):1248-54. DOI: 10.1164/rccm.200706-877OC. View

11.

Raghu G, Remy-Jardin M, Myers J, Richeldi L, Ryerson C, Lederer D . Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5):e44-e68. DOI: 10.1164/rccm.201807-1255ST. View

12.

Fischer A, Swigris J, Bolster M, Chung L, Csuka M, Domsic R . Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. Clin Exp Rheumatol. 2014; 32(6 Suppl 86):S-109-14. View

13.

Flaherty K, Wells A, Cottin V, Devaraj A, Walsh S, Inoue Y . Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med. 2019; 381(18):1718-1727. DOI: 10.1056/NEJMoa1908681. View

14.

Wells A, King A, Rubens M, Cramer D, du Bois R, Hansell D . Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med. 1997; 155(4):1367-75. DOI: 10.1164/ajrccm.155.4.9105081. View

15.

Matsuoka S, Washko G, Dransfield M, Yamashiro T, San Jose Estepar R, Diaz A . Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol. 2009; 17(1):93-9. PMC: 2790546. DOI: 10.1016/j.acra.2009.07.022. View

16.

Flaherty K, Kolb M, Vancheri C, Tang W, Conoscenti C, Richeldi L . Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2018; 52(2). DOI: 10.1183/13993003.02593-2017. View

17.

Allen S, Baxter M . A comparison of four tests of cognition as predictors of inability to perform spirometry in old age. Age Ageing. 2009; 38(5):537-41. DOI: 10.1093/ageing/afp104. View

18.

Jacob J, Bartholmai B, Rajagopalan S, Kokosi M, Nair A, Karwoski R . Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function. J Thorac Imaging. 2016; 31(5):304-11. DOI: 10.1097/RTI.0000000000000220. View

19.

Noble P, Albera C, Bradford W, Costabel U, Glassberg M, Kardatzke D . Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011; 377(9779):1760-9. DOI: 10.1016/S0140-6736(11)60405-4. View

20.

Robbie H, Daccord C, Chua F, Devaraj A . Evaluating disease severity in idiopathic pulmonary fibrosis. Eur Respir Rev. 2017; 26(145). PMC: 9488723. DOI: 10.1183/16000617.0051-2017. View